TANG Capital Partners L.P., Chief Financial Officer, Officer, Chief Executive Officer, 10% Owner at Odonate Therapeutics, Inc. (ODT), bought 80,000 shares at $18.95 ($1.5M) on 2018-09-28, disclosed to the SEC on 2018-10-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.70 | 6,199 | $116K | 7.6% |
| 2 | $18.70 | 6,199 | $116K | 7.6% |
| 3 | $18.95 | 3,801 | $72K | 4.7% |
| 4 | $18.95 | 3,801 | $72K | 4.7% |
| 5 | $19.17 | 10,000 | $192K | 12.5% |
| 6 | $19.17 | 10,000 |
| $192K |
| 12.5% |
| 7 | $19.33 | 20,000 | $387K | 25.2% |
| 8 | $19.33 | 20,000 | $387K | 25.2% |
| Total | $19.16 avg | 80,000 | $1.5M | 100% |
| Filing → |
| TCRR | BUY | 2023-05-10 | $275K | — | Filing → |
| TCRR | BUY | 2023-05-05 | $1.1M | — | Filing → |
| LJPC | SELL | 2021-12-01 | $3.4M | — | Filing → |